Literature DB >> 19620028

Simultaneous quantification of 5-FU, 5-FUrd, 5-FdUrd, 5-FdUMP, dUMP and TMP in cultured cell models by LC-MS/MS.

Delphine Carli1, Mylène Honorat, Sabine Cohen, Mehdi Megherbi, Bruno Vignal, Charles Dumontet, Léa Payen, Jérôme Guitton.   

Abstract

To specifically quantify several metabolites of 5-fluorouracil (5-FU) and two endogenous monophosphate nucleotides, we developed an original method based on a liquid chromatography-tandem mass spectrometry (LC-MS/MS). This assay allowed the determination of: (i) the intracellular production of 5-fluoro-2'-deoxyuridine-5'-monophosphate (5-FdUMP) from 5-FU or 5-fluoro-2'-deoxyuridine (5-FdUrd), (ii) the impact of 5-FdUMP concentration on the intracellular 2'-deoxyuridine-5'-monophosphate (dUMP)/thymidine-5'-monophosphate (TMP) ratio, and (iii) the secretion extent of 5-FdUMP and 5-FU from human cultured cells by ABC transporters. Under our experimental conditions, cells were incubated with 5-FU or 5-FUrd. Then, cellular proteins were precipitated by methanol. This procedure provided high extraction recovery. In addition, to measure 5-FU and 5-FdUMP secretion from cells, we carried out quantification of these molecules in culture medium. Media were either directly injected (5-FU) or underwent a solid phase extraction using Oasis Wax extraction cartridge (5-FdUMP). Separation of analytes was performed on a dC18 Atlantis 3.5microm, (100mmx2.1mm i.d) column with isocratic mode using ammonium formate buffer/methanol/water (5/5/90, v/v) as mobile phase. The run time did not exceed 6.2min. The analytes were ionized in an electrospray interface under negative ion mode. We validated the method over a range of 2.5-150ngmL(-1) according to the compounds. Intra- and inter-assay variability was lower than 10% over seven days. All compounds were stable in cells or in culture medium when samples were stored at -20 degrees C for at least two weeks, and after three freeze-thaw cycles. No matrix effect was observed in both media.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620028     DOI: 10.1016/j.jchromb.2009.07.004

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  11 in total

1.  Fluorescence and electrochemical recognition of nucleosides and DNA by a novel luminescent bioprobe Eu(III)-TNB.

Authors:  Hassan A Azab; E M Mogahed; F K Awad; R M Abd El Aal; Rasha M Kamel
Journal:  J Fluoresc       Date:  2012-05       Impact factor: 2.217

2.  The achievement of mass balance by simultaneous quantification of floxuridine prodrug, floxuridine, 5-fluorouracil, 5-dihydrouracil, α-fluoro-β-ureidopropionate, α-fluoro-β-alanine using LC-MS.

Authors:  Yasuhiro Tsume; Chester J Provoda; Gordon L Amidon
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-03-05       Impact factor: 3.205

Review 3.  A Critical Review on Clinical Application of Separation Techniques for Selective Recognition of Uracil and 5-Fluorouracil.

Authors:  Khushaboo Pandey; Rama Shankar Dubey; Bhim Bali Prasad
Journal:  Indian J Clin Biochem       Date:  2015-02-15

4.  Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses.

Authors:  Ron J Keizer; Robert S Jansen; Hilde Rosing; Bas Thijssen; Jos H Beijnen; Jan H M Schellens; Alwin D R Huitema
Journal:  Pharmacol Res Perspect       Date:  2015-03-25

5.  Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression.

Authors:  Kazuaki Matsuoka; Fumio Nakagawa; Takashi Kobunai; Teiji Takechi
Journal:  Oncotarget       Date:  2018-02-05

6.  Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells.

Authors:  Loredana Bergandi; Eleonora Mungo; Rosa Morone; Ornella Bosco; Barbara Rolando; Sophie Doublier
Journal:  Front Pharmacol       Date:  2018-08-13       Impact factor: 5.810

7.  A High-Resolution Mass Spectrometry-Based Quantitative Metabolomic Workflow Highlights Defects in 5-Fluorouracil Metabolism in Cancer Cells with Acquired Chemoresistance.

Authors:  Sanjay Shahi; Ching-Seng Ang; Suresh Mathivanan
Journal:  Biology (Basel)       Date:  2020-05-06

8.  DCTPP1 attenuates the sensitivity of human gastric cancer cells to 5-fluorouracil by up-regulating MDR1 expression epigenetically.

Authors:  Li-Liang Xia; Ya-Bin Tang; Fei-Fei Song; Ling Xu; Ping Ji; Shu-Jun Wang; Ji-Min Zhu; Yong Zhang; Guo-Ping Zhao; Ying Wang; Tao-Tao Liu
Journal:  Oncotarget       Date:  2016-10-18

9.  Pharmacokinetics of continuous transarterial infusion of 5-fluorouracil in patients with advanced hepatocellular carcinoma.

Authors:  Jian Gao; Rui Zhen; Hai Liao; Wenquan Zhuang; Wenbo Guo
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

10.  A novel approach to the application of hexagonal mesoporous silica in solid-phase extraction of drugs.

Authors:  Fatemeh Farjadian; Soha Azadi; Soliman Mohammadi-Samani; Hajar Ashrafi; Amir Azadi
Journal:  Heliyon       Date:  2018-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.